| Similar Articles |
|---|
 |
American Family Physician
March 1, 2002
Richard S. Safeer |
Cholesterol Treatment Guidelines Update In addition to modifying current strategies of risk assessment, the new guidelines stress the importance of an aggressive therapeutic approach in the management of hypercholesterolemia...   |
American Family Physician
December 15, 2000
Alan J. Garber |
Attenuating Cardiovascular Risk Factors in Patients with Type 2 Diabetes All cardiovascular risk factors except smoking are more prevalent in patients with type 2 diabetes. In addition to exercise, weight control, aspirin therapy and blood pressure control, therapy to modify lipid profiles is usually necessary... |
American Family Physician
March 15, 2005
Lockman et al. |
Treatment of Cholesterol Abnormalities The relationship between coronary heart disease and elevated cholesterol levels has been recognized for many years, but now studies show an improvement in patient-oriented outcomes in patients receiving drug therapy. |
American Family Physician
June 15, 2005
Hanna & Wenger |
Secondary Prevention of Coronary Heart Disease in Elderly Patients A review of the scientific evidence for the secondary prevention of coronary heart disease in the elderly. |
Nurse Practitioner
July 2010
Kristine A. Scordo |
Treating antiretroviral-induced dyslipidemia in HIV-infected adults Studies indicate that HIV-infected patients (both males and females) may be at an increased risk for the development of cardiovascular disease |
American Family Physician
October 15, 2006
Sharonne N. Hayes |
Preventing Cardiovascular Disease in Women The American Heart Association guidelines for cardiovascular disease prevention in women provide physicians with a clear plan for assessment and treatment of cardiovascular disease risk and personalization of treatment recommendations. |
American Family Physician
July 15, 2005
Lee Radosh |
STEPS: Colesevelam (WelChol) for Reduction of LDL Cholesterol Colesevelam lowers LDL cholesterol levels a small amount (7% to 16%) when used alone and provides additional cholesterol lowering when added to statin therapy. |
American Family Physician
October 15, 2003
Gavin et al. |
Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes By increasing patient awareness of the link between diabetes and heart disease, family physicians can encourage patients to take medications (including aspirin), stop smoking, lower blood pressure, and lower cholesterol and blood glucose levels. |
American Family Physician
April 1, 2001
Joan Bedinghaus |
Coronary Artery Disease Prevention: What's Different for Women? Cardiovascular disease is the leading cause of death in women, as well as an important cause of disability, although many women and their physicians underestimate the risk... |
American Family Physician
August 1, 2004
Wiviott & Braunwald |
Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: Part II. Coronary Revascularization, Hospital Discharge, and Post-Hospital Care In patients hospitalized with UA/NSTEMI, one of the most important decisions is the early strategy of care regarding coronary angiography and revascularization. |
Nurse Practitioner
February 2012
Wood & Gordon |
Preventing CVD in women: The NP's role This article focuses on the new American Heart Association guidelines for preventing cardiovascular disease in women and the nurse practitioner's role in implementing them. |
American Family Physician
December 15, 2003
Ezekowitz et al. |
Stroke: Strategies for Primary Prevention Stroke is a leading cause of morbidity and mortality. Every year, approximately 500,000 Americans have a first stroke, and approximately 20 percent die within 30 days. This article summarizes strategies that have been shown to be effective in stroke prevention. |
American Family Physician
November 15, 2005
Goldman-Levine & Bohlman |
STEPS Review of the drug EZetimibe/Simvastatin used for hypercholesterolemia. |
American Family Physician
June 15, 2004
Darwin Deen |
Metabolic Syndrome: Time for Action Family physicians can be more effective in helping patients to change their lifestyle behaviors by assessing each patient for the presence of specific risk factors, clearly communicating these risk factors to patients, identifying appropriate interventions to address specific risks, and assisting patients in identifying barriers to behavior change. |
Nursing Management
August 2008
Jill R. Quinn |
Women and Heart Disease: An Update A look at statistics regarding coronary heart disease in women as well as related risk factors and prevention. |
American Family Physician
April 15, 2004
Rao, Disraeli & Mcgregor |
Impaired Glucose Tolerance and Impaired Fasting Glucose Impaired glucose tolerance and impaired fasting glucose form an intermediate stage in the natural history of diabetes mellitus. |
American Family Physician
October 15, 2003
Morris & Tiller |
Ezetimibe for Hypercholesterolemia Ezetimibe is safe and effective for lowering LDL cholesterol and triglyceride levels, but has not been shown to affect patient-oriented outcomes. |
American Family Physician
October 15, 2005
Kathy Soch |
Diary From a Week in Pactice This family practitioner checks in on a patient with severe expressive aphasia... Sees a chronic pessimist... Recommends documenting a resident's pre-operative clearance for a patient... etc. |
American Family Physician
August 1, 2002
Daphne P. Bicket |
Using ACE Inhibitors Appropriately Although angiotensin-converting enzyme (ACE) inhibitors have documented clinical benefits in a variety of clinical situations, the disparity between the evidence from clinical trials and bedside medicine is well documented. |
Managed Care
April 2004
Jack McCain |
Statin Therapy: More Than Meets the Eye? Statin selection has just become more complicated. Will physicians be diverted from interventions that may be less costly and just as effective? |
BusinessWeek
April 19, 2004
Catherine Arnst |
Cholesterol: How Low Should It Be? New studies say as low as possible, but drugs aren't for everybody |
American Family Physician
July 15, 2000
Ethan M. Berke & Nancy E. Morden |
Medical Management of Obesity Family physicians must treat any conditions associated with obesity while working with patients on methods to achieve and maintain weight loss... |
American Family Physician
August 1, 2000
Mark R. Ellis & Kevin Y. Kane |
Lightening the Lead Load in Children The causes and effects of lead poisoning on children. |
Nurse Practitioner
September 2011
Wells & Kalman |
Women & Heart Disease: Symptoms and Treatment Guidelines Coronary heart disease is the leading cause of death for women. Nurse practitioners need to educate women about their risk and follow practice guidelines. |
American Family Physician
May 1, 2001
Beatriz Luna & Mark N. Feinglos |
Oral Agents in the Management of Type 2 Diabetes Mellitus Currently, there are five distinct classes of hypoglycemic agents available, each class displaying unique pharmacologic properties... |
The Motley Fool
December 23, 2003
Arash Mostaghimi |
The Cholesterol Wars Who will win the fight to save your arteries? Fortunately for our corpulent country, pharmaceutical companies want to unclog our arteries -- and lighten our wallets. But which pharma stock will add to most girth to a portfolio? |
BusinessWeek
December 13, 2004
Kate Murphy |
Cholesterol: The Bigger the Better Many doctors are convinced that getting a more thorough cholesterol test, one that identifies the types of LDL particles, can improve treatment and save lives. |
Nurse Practitioner
February 2011
Jennifer M. Belavic |
Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available. |
American Family Physician
March 15, 2006
Wilson & Sanford |
Amlodipine/Atorvastatin (Caduet) for Preventing Heart Disease Amlodipine/atorvastatin offers no added benefit in safety, tolerability, or effectiveness over amlodipine and atorvastatin taken separately. It has not been shown to improve mortality or morbidity in patients who have hypertension with or without dyslipidemia. |
The Motley Fool
December 4, 2006
Michael P. Cecil |
Pfizer's Cholesterol-Drug Hopes Crumble In surprising and disappointing news, the pharma's promising new drug fails clinical trials. With Pfizer shares declining because of the bad news, is now a good time to buy? |
American Family Physician
November 15, 2004
Snively & Gutierrez |
Chronic Kidney Disease: Prevention and Treatment of Common Complications Family physicians have the opportunity to screen at-risk patients, identify affected patients, and ameliorate the impact of chronic kidney disease by initiating early therapy and monitoring disease progression. |
Nutrition Action Healthletter
October 2001 |
Read My Lipids How to lower your risk of a heart attack... |
Nursing
June 2010
Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
American Family Physician
December 1, 2004
McConaghy & Smith |
Outpatient Treatment of Systolic Heart Failure Optimal outpatient treatment of systolic heart failure has three goals that should be pursued simultaneously: (1) control of risk factors for the development and progression of heart failure, (2) treatment of heart failure, and (3) education of patients. |
American Family Physician
September 15, 2000
Vincent Morelli, M.D. & Roger J. Zoorob, M.D., M.P.H. |
Alternative Therapies: Part II. Congestive Heart Failure and Hypercholesterolemia Natural supplements are widely used by the American public but, while claims of their therapeutic effects abound, medical research does not always support their effectiveness... |
American Family Physician
August 15, 2003
Marilyn R. Richardson |
Current Perspectives in Polycystic Ovary Syndrome The purpose of this review is to examine the clinical course of this syndrome, which spans adolescence through menopause, and suggest a simple and cost-effective diagnostic evaluation to screen the large numbers of women who may be affected. |
American Family Physician
November 1, 2003
Turok et al. |
Management of Gestational Diabetes Mellitus Although the disorder affects approximately 2.5 percent of pregnant women and has been the subject of extensive research, its diagnosis and management continue to be debated. |
Nursing
September 2010
Margaret M. Bolton |
Sounding the alarm about metabolic syndrome Any health problem that affects a third of American adults is sure to impact your nursing practice. Metabolic syndrome, a growing and commonly silent condition, poses a significant public health crisis. |
American Family Physician
October 15, 2000
Matthew Neff |
Conference Highlights Lifestyle Modifications Can Prevent Onset of Type 2 Diabetes... Efficacy of Metformin Is Similar in Children and Adults... Glycemic Control Improves Quality of Life in Patients with Diabetes... Test Strip Proves Effective, Less Painful Alternative to Fingerstick... |
Managed Care
November 2004
Martin Sipkoff |
OTC Status for Low-Dose Lovastatin Would Have Widespread Implications The FDA stands poised to approve OTC low-dose statins, following a similar change in United Kingdom. |
American Family Physician
March 15, 2005 |
What Should I Know About Cholesterol? A patient hand-out on how cholesterol levels effect the likelihood of heart attack and stroke. |
Pharmaceutical Executive
February 1, 2009
Walter Armstrong |
Brand of the Year: Crestor For aiming to be a game-changer in cardiovascular disease, we recognize comeback kid Crestor as the year's No. 1. Plus three fine finalists. |
Pharmaceutical Executive
May 1, 2006
Ron Feemster |
Teamsters v. Pfizer A New Jersey Teamsters local says Pfizer tricked them into paying for off-label Lipitor prescriptions. Do you have any questions about that? We do. |
Nursing
February 2010
Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
American Family Physician
November 15, 2002
Cynthia M. Williams |
Using Medications Appropriately in Older Adults Finding the right balance between too few and too many drugs will help ensure increased longevity, improved overall health, and enhanced functioning and quality of life for the aging population. |
Chemistry World
September 18, 2015
Rebecca Trager |
Amgen expands cardiovascular portfolio with Dezima acquisition Dezima's lead molecule is the cholesterol-lowering drug TA-8995. |
American Family Physician
February 1, 2004
Lesho et al. |
Management of Peripheral Arterial Disease Peripheral arterial disease is common, but the diagnosis frequently is overlooked because of subtle physical findings and lack of classic symptoms. |
American Journal of Nursing
May 2009
Kristen J. Overbaugh |
Acute Coronary Syndrome Coronary artery disease, in which atherosclerotic plaque builds up inside the coronary arteries and restricts the flow of blood (and therefore the delivery of oxygen) to the heart, continues to be the number-one killer of Americans. |
Nurse Practitioner
July 2011
Kass-Wolff & Fisher |
Menopause and the Hormone Controversy: Clarification or Confusion? Hormone therapy in perimenopause and menopause remains a controversial and often confusing management strategy for healthcare providers. To assist in providing women quality healthcare, recently published new guidelines help provide direction for NPs. |
Nursing
June 2011
Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
